APPRAISE-RS: Automated, updated, participatory, and personalized treatment recommender systems based on GRADE methodology

Attention deficit hyperactivity disorder; Evidence-based medicine; Meta-analysisTrastorn per dèficit d'atenció amb hiperactivitat; Medicina basada en l'evidència; MetaanàlisiTrastorno por déficit de atención con hiperactividad; Medicina basada en la evidencia; MetanálisisPurpose: Clinical practice guidelines (CPGs) have become fundamental tools for evidence-based medicine (EBM). However, CPG suffer from several limitations, including obsolescence, lack of applicability to many patients, and limited patient participation. This paper presents APPRAISE-RS, which is a methodology that we developed to overcome these limitations by automating, extending, and iterating the methodology that is most commonly used for building CPGs: the GRADE methodology.Method: APPRAISE-RS relies on updated information from clinical studies and adapts and automates the GRADE methodology to generate treatment recommendations. APPRAISE-RS provides personalized recommendations because they are based on the patient's individual characteristics. Moreover, both patients and clinicians express their personal preferences for treatment outcomes which are considered when making the recommendation (participatory). Rule-based system approaches are used to manage heuristic knowledge.Results: APPRAISE-RS has been implemented for attention deficit hyperactivity disorder (ADHD) and tested experimentally on 28 simulated patients. The resulting recommender system (APPRAISE-RS/TDApp) shows a higher degree of treatment personalization and patient participation than CPGs, while recommending the most frequent interventions in the largest body of evidence in the literature (EBM). Moreover, a comparison of the results with four blinded psychiatrist prescriptions supports the validation of the proposal.Conclusions: APPRAISE-RS is a valid methodology to build recommender systems that manage updated, personalized and participatory recommendations, which, in the case of ADHD includes at least one intervention that is identical or very similar to other drugs prescribed by psychiatrists.This work was supported by European Regional Development Fund (ERDF), the Spanish Ministry of the Economy, Industry and Competitiveness (MINECO) and the Carlos III Research Institute [PI19/00375], Fundació Pascual i Prats & Campus Salut, UdG [AIN2018E], Generalitat de Catalunya [2017 SGR 1551]

Health Recommender Systems Development, Usage, and Evaluation from 2010 to 2022: A Scoping Review

A health recommender system (HRS) provides a user with personalized medical information based on the user’s health profile. This scoping review aims to identify and summarize the HRS development in the most recent decade by focusing on five key aspects: health domain, user, recommended item, recommendation technology, and system evaluation. We searched PubMed, ACM Digital Library, IEEE Xplore, Web of Science, and Scopus databases for English literature published between 2010 and 2022. Our study selection and data extraction followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. The following are the primary results: sixty-three studies met the eligibility criteria and were included in the data analysis. These studies involved twenty-four health domains, with both patients and the general public as target users and ten major recommended items. The most adopted algorithm of recommendation technologies was the knowledge-based approach. In addition, fifty-nine studies reported system evaluations, in which two types of evaluation methods and three categories of metrics were applied. However, despite existing research progress on HRSs, the health domains, recommended items, and sample size of system evaluation have been limited. In the future, HRS research shall focus on dynamic user modelling, utilizing open-source knowledge bases, and evaluating the efficacy of HRSs using a large sample size. In conclusion, this study summarized the research activities and evidence pertinent to HRSs in the most recent ten years and identified gaps in the existing research landscape. Further work shall address the gaps and continue improving the performance of HRSs to empower users in terms of healthcare decision making and self-management

Clinical evaluation of a novel adaptive bolus calculator and safety system in Type 1 diabetes

Bolus calculators are considered state-of-the-art for insulin dosing decision support for people with Type 1 diabetes (T1D). However, they all lack the ability to automatically adapt in real-time to respond to an individual’s needs or changes in insulin sensitivity. A novel insulin recommender system based on artificial intelligence has been developed to provide personalised bolus advice, namely the Patient Empowerment through Predictive Personalised Decision Support (PEPPER) system. Besides adaptive bolus advice, the decision support system is coupled with a safety system which includes alarms, predictive glucose alerts, predictive low glucose suspend for insulin pump users, personalised carbohydrate recommendations and dynamic bolus insulin constraint. This thesis outlines the clinical evaluation of the PEPPER system in adults with T1D on multiple daily injections (MDI) and insulin pump therapy. The hypothesis was that the PEPPER system is safe, feasible and effective for use in people with TID using MDI or pump therapy. Safety and feasibility of the safety system was initially evaluated in the first phase, with the second phase evaluating feasibility of the complete system (safety system and adaptive bolus advisor). Finally, the whole system was clinically evaluated in a randomised crossover trial with 58 participants. No significant differences were observed for percentage times in range between the PEPPER and Control groups. For quality of life, participants reported higher perceived hypoglycaemia with the PEPPER system despite no objective difference in time spent in hypoglycaemia. Overall, the studies demonstrated that the PEPPER system is safe and feasible for use when compared to conventional therapy (continuous glucose monitoring and standard bolus calculator). Further studies are required to confirm overall effectiveness.Open Acces